China · Delayed Price · Currency is CNY APT Medical Statistics
Total Valuation
APT Medical has a market cap or net worth of CNY 36.00 billion. The enterprise value is 34.62 billion.
| Market Cap | 36.00B |
| Enterprise Value | 34.62B |
Important Dates
The last earnings date was Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | May 14, 2026 |
Share Statistics
APT Medical has 139.23 million shares outstanding. The number of shares has decreased by -0.26% in one year.
| Current Share Class | 139.23M |
| Shares Outstanding | 139.23M |
| Shares Change (YoY) | -0.26% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 20.32% |
| Owned by Institutions (%) | 30.54% |
| Float | 73.51M |
Valuation Ratios
The trailing PE ratio is 39.14 and the forward PE ratio is 36.09.
| PE Ratio | 39.14 |
| Forward PE | 36.09 |
| PS Ratio | 12.43 |
| PB Ratio | 11.54 |
| P/TBV Ratio | 13.55 |
| P/FCF Ratio | 42.10 |
| P/OCF Ratio | 33.57 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.75, with an EV/FCF ratio of 40.49.
| EV / Earnings | 37.12 |
| EV / Sales | 11.95 |
| EV / EBITDA | 30.75 |
| EV / EBIT | 34.33 |
| EV / FCF | 40.49 |
Financial Position
The company has a current ratio of 4.67, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.67 |
| Quick Ratio | 3.45 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | 621.04 |
Financial Efficiency
Return on equity (ROE) is 30.82% and return on invested capital (ROIC) is 50.71%.
| Return on Equity (ROE) | 30.82% |
| Return on Assets (ROA) | 18.43% |
| Return on Invested Capital (ROIC) | 50.71% |
| Return on Capital Employed (ROCE) | 31.71% |
| Weighted Average Cost of Capital (WACC) | 2.16% |
| Revenue Per Employee | 851,654 |
| Profits Per Employee | 274,271 |
| Employee Count | 3,401 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 1.72 |
Taxes
In the past 12 months, APT Medical has paid 143.46 million in taxes.
| Income Tax | 143.46M |
| Effective Tax Rate | 13.53% |
Stock Price Statistics
The stock price has decreased by -7.85% in the last 52 weeks. The beta is -0.38, so APT Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.38 |
| 52-Week Price Change | -7.85% |
| 50-Day Moving Average | 208.94 |
| 200-Day Moving Average | 233.96 |
| Relative Strength Index (RSI) | 71.29 |
| Average Volume (20 Days) | 1,821,768 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, APT Medical had revenue of CNY 2.90 billion and earned 932.79 million in profits. Earnings per share was 6.61.
| Revenue | 2.90B |
| Gross Profit | 2.10B |
| Operating Income | 1.01B |
| Pretax Income | 1.06B |
| Net Income | 932.79M |
| EBITDA | 1.12B |
| EBIT | 1.01B |
| Earnings Per Share (EPS) | 6.61 |
Balance Sheet
The company has 1.42 billion in cash and 13.74 million in debt, with a net cash position of 1.41 billion or 10.13 per share.
| Cash & Cash Equivalents | 1.42B |
| Total Debt | 13.74M |
| Net Cash | 1.41B |
| Net Cash Per Share | 10.13 |
| Equity (Book Value) | 3.12B |
| Book Value Per Share | 22.17 |
| Working Capital | 1.61B |
Cash Flow
In the last 12 months, operating cash flow was 1.07 billion and capital expenditures -217.38 million, giving a free cash flow of 855.01 million.
| Operating Cash Flow | 1.07B |
| Capital Expenditures | -217.38M |
| Depreciation & Amortization | 108.23M |
| Net Borrowing | 5.24M |
| Free Cash Flow | 855.01M |
| FCF Per Share | 6.14 |
Margins
Gross margin is 72.36%, with operating and profit margins of 34.82% and 32.20%.
| Gross Margin | 72.36% |
| Operating Margin | 34.82% |
| Pretax Margin | 36.60% |
| Profit Margin | 32.20% |
| EBITDA Margin | 38.56% |
| EBIT Margin | 34.82% |
| FCF Margin | 29.52% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.44%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.44% |
| Dividend Growth (YoY) | -42.86% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 14.92% |
| Buyback Yield | 0.26% |
| Shareholder Yield | 0.69% |
| Earnings Yield | 2.59% |
| FCF Yield | 2.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for APT Medical is 328.38, which is 27.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 328.38 |
| Price Target Difference | 27.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 24.36% |
| EPS Growth Forecast (3Y) | 27.50% |
Stock Splits
The last stock split was on June 19, 2025. It was a forward split with a ratio of 1.45.
| Last Split Date | Jun 19, 2025 |
| Split Type | Forward |
| Split Ratio | 1.45 |
Scores
APT Medical has an Altman Z-Score of 47.15 and a Piotroski F-Score of 6.
| Altman Z-Score | 47.15 |
| Piotroski F-Score | 6 |